Stress sensitivity in patients with atopic dermatitis in relation to the translocator protein 18 kDa (TSPO)

Journal of Nippon Medical School

Volumn 81, Issue 3, 2014, Pages 148-156

  Kaga, Mio ^a,b   Nakamoto, Yurie ^b   Nakamura, Kazuhiko ^c   Ikeda, Kazutaka ^b   Yoshii, Mitsunobu ^b   Kawana, Seiji ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; Genomic analysis; Stress sensitivity; Translocator protein 18 kDa (TSPO)

Indexed keywords

BENZODIAZEPINE RECEPTOR; BIOLOGICAL MARKER; GENOMIC DNA; 4 AMINOBUTYRIC ACID RECEPTOR; ISOQUINOLINE DERIVATIVE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; TRITIUM; TSPO PROTEIN, HUMAN;

ANXIETY; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DISEASE SEVERITY; EXON; FEMALE; GENE; GENE FREQUENCY; GENE SEQUENCE; GENOME ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RECEPTOR BINDING ASSAY; SINGLE NUCLEOTIDE POLYMORPHISM; STATE TRAIT ANXIETY INVENTORY; STRESS; THROMBOCYTE MEMBRANE; TRANSLOCATOR PROTEIN GENE; ALLELE; GENETIC PREDISPOSITION; GENETICS; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PSYCHOLOGY; RADIOASSAY; SEVERITY OF ILLNESS INDEX;

ALLELES; ANXIETY; DERMATITIS, ATOPIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ISOQUINOLINES; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIOLIGAND ASSAY; RECEPTORS, GABA; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; TRITIUM;

EID: 84902332121     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.81.148     Document Type: Article

References (24)

1. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al.: Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-446.
2. O'Regan GM, Sandilands A, McLean WH, Irvine AD: Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2008; 122: 689-693.
3. Bender BG, Ballard R, Canono B, Murphy JR, Leung DY: Disease severity, scratching, and sleep quality in patients with atopic dermatitis. J Am Acad Dermatol 2008; 58: 415-420.
4. Buske-Kirschbaum A, Geiben A, Hellhammer D: Psychobiological aspects of atopic dermatitis: an overview. Psychother Psychosom 2001; 70: 6-16.
5. Howlett S: Emotional dysfunction, child-family relationships and childhood atopic dermatitis. Br J Dermatol 1999; 140: 381-384.
6. Linnet J, Jemec GB: Anxiety level and severity of skin condition predicts outcome of psychotherapy in atopic dermatitis patients. Int J Dermatol 2001; 40: 632-636.
7. Hashizume H, Takigawa M: Anxiety in allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol 2006; 6: 335-339.
8. Gavish M, Bachman I, Shoukrun R, et al.: Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 1999; 51: 629-650.
9. Papadopoulos V, Lecanu L, Brown RC, et al.: Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience 2006; 138: 749-756.
10. Papadopoulos V, Baraldi M, Guilarte TR, et al.: Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 2006; 27: 402-409.
11. Nakamura K, Fukunishi I, Nakamoto Y, Iwahashi K, Yoshii M: Peripheral-type benzodiazepine receptors on platelets are correlated with the degrees of anxiety in normal human subjects. Psychopharmacology 2002; 162: 301-303.
12. Nakamura K, Yamada K, Iwayama Y, et al.: Evidence that variation in the peripheral benzodiazepine receptor (PBR) gene influences susceptibility to panic disorder. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 222-226.
13. Nakamoto Y, Watabe S, Shiotani T, Yoshii M: Peripheral-type benzodiazepine receptors in association with epileptic seizures in EL mice. Brain Res 1996; 717: 91-98.
14. Ranade K, Chang MS, Ting CT, et al.: Highthroughput genotyping with single nucleotide polymorphisms. Genome Res 2001; 11: 1262-1268.
15. Rupprecht R, Papadopoulos V, Rammes G, et al.: Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nature Rev 2010; 9: 971-988.
16. Kinnally KW, Zorov DB, Antonenko YN, et al.: Mitochondrial benzodiazepine receptor linked to inner membrane ion channels by nanomolar actions of ligands. Proc Natl Acad Sci USA 1993; 90: 1374-1378.
17. Drugan RC, Basile AS, Crawly JN, et al.: Inescapable shock reduces [3H]Ro 5-4864 binding to "peripheraltype" benzodiazepine receptors in the rat. Pharmacol Biochem Behav 1986; 24: 1673-1677.
18. Arck P, Paus R: From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch. Neuroimmunomodulation 2006; 13: 347-356.
19. Arndt J, Smith N, Tausk F: Stress and atopic dermatitis. Curr Allergy Asthma Rep 2008; 8: 312-317.
20. Wright RJ, Finn P, Contreras JP, et al.: Chronic caregiver stress and IgE expression, allergeninduced proliferation, and cytokine profiles in a birth cohort predisposed to atopy. J Allergy Clin Immunol 2004; 113: 1051-1057.
21. Alleva E, Petruzzi S, Cirulli F, Aloe L: NGF regulatory role in stress and coping of rodents and humans. Pharmacol Biochem Behav 1996; 54: 65-72.
22. Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M: Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002; 147: 71-79.
23. Oh SH, Bae BG, Park CO, et al.: Association of stress with symptoms of atopic dermatitis. Acta Derm Venereol 2010; 90: 582-588.
24. Wilms H, Claasen J, Röhl C, et al.: Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro. Neurobiol Dis 2003; 14: 417-424.